论文部分内容阅读
75例口腔颌面及颈部恶性淋巴瘤采用了化学治疗.分析了瘤细胞分型与化疗效果及预后之间的关系.4例非何杰金淋巴瘤中滤泡型音:中细胞型2例,混合细胞型及大细胞型各1例,五年生存率皆为100%,显示其预后良好.弥漫型的细胞分型及五年生存率:小细胞型为 15.3%(13例),中细胞型为23%(13例),混合细胞型为18.7%(16例),显示其预后较差.而大细胞型(8例)、淋巴母细胞(10例)、巴基特型(1例)等五年生存率皆为0%,显示这些肿瘤预后极差.本组10例何杰金氏淋巴瘤,其中淋巴细胞为主型2例,结节硬化型3例,其五年生存率皆为100%;混合细胞型(4例)为50%,淋巴细胞消减型(1例)五年生存率为0%.
Seventy-five cases of malignant oral lymphomas of the oral and maxillofacial region were treated with chemotherapy. The relationship between tumor cell type, chemotherapy effect, and prognosis was analyzed. Four cases of non-Hodgkin’s lymphoma in the follicular type: medium cell type 2 In one case, mixed cell type and large cell type, the five-year survival rate was 100%, indicating a good prognosis. Diffuse cell type and five-year survival rate: 15.3% (13 cases) of small cell type, The median cell type was 23% (13 cases), and the mixed cell type was 18.7% (16 cases), indicating a poor prognosis. Large cell type (8 cases), lymphoblasts (10 cases), and Burkitt type ( One case) and other five-year survival rates were all 0%, indicating that the prognosis of these tumors is very poor. The group of 10 cases of Hodgkin’s lymphoma, of which 2 cases of lymphocyte-predominant type, 3 cases of nodular sclerosis, its 5 years The survival rate was 100%; the mixed cell type (4 cases) was 50%; the lymphocyte depletion type (1 case) had a five-year survival rate of 0%.